IBDEI1XI ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34248,0)
 ;;=N14.0^^192^1994^1
 ;;^UTILITY(U,$J,358.3,34248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34248,1,3,0)
 ;;=3^Analgesic Nephropathy
 ;;^UTILITY(U,$J,358.3,34248,1,4,0)
 ;;=4^N14.0
 ;;^UTILITY(U,$J,358.3,34248,2)
 ;;=^5015590
 ;;^UTILITY(U,$J,358.3,34249,0)
 ;;=N15.0^^192^1994^2
 ;;^UTILITY(U,$J,358.3,34249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34249,1,3,0)
 ;;=3^Balkan Nephropathy
 ;;^UTILITY(U,$J,358.3,34249,1,4,0)
 ;;=4^N15.0
 ;;^UTILITY(U,$J,358.3,34249,2)
 ;;=^12543
 ;;^UTILITY(U,$J,358.3,34250,0)
 ;;=N18.9^^192^1994^3
 ;;^UTILITY(U,$J,358.3,34250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34250,1,3,0)
 ;;=3^Chr Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,34250,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,34250,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,34251,0)
 ;;=N28.9^^192^1994^17
 ;;^UTILITY(U,$J,358.3,34251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34251,1,3,0)
 ;;=3^Kidney/Ureter Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,34251,1,4,0)
 ;;=4^N28.9
 ;;^UTILITY(U,$J,358.3,34251,2)
 ;;=^5015630
 ;;^UTILITY(U,$J,358.3,34252,0)
 ;;=N40.0^^192^1994^4
 ;;^UTILITY(U,$J,358.3,34252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34252,1,3,0)
 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,34252,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,34252,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,34253,0)
 ;;=N07.6^^192^1994^5
 ;;^UTILITY(U,$J,358.3,34253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34253,1,3,0)
 ;;=3^Hereditary Nephropathy w/ Dense Deposit Disease NEC
 ;;^UTILITY(U,$J,358.3,34253,1,4,0)
 ;;=4^N07.6
 ;;^UTILITY(U,$J,358.3,34253,2)
 ;;=^5015565
 ;;^UTILITY(U,$J,358.3,34254,0)
 ;;=N07.7^^192^1994^6
 ;;^UTILITY(U,$J,358.3,34254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34254,1,3,0)
 ;;=3^Hereditary Nephropathy w/ Diffuse Crescentic Glomerular NEC
 ;;^UTILITY(U,$J,358.3,34254,1,4,0)
 ;;=4^N07.7
 ;;^UTILITY(U,$J,358.3,34254,2)
 ;;=^5015566
 ;;^UTILITY(U,$J,358.3,34255,0)
 ;;=N07.1^^192^1994^7
 ;;^UTILITY(U,$J,358.3,34255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34255,1,3,0)
 ;;=3^Hereditary Nephropathy w/ Focal/Segmental Glomerular Lesions NEC
 ;;^UTILITY(U,$J,358.3,34255,1,4,0)
 ;;=4^N07.1
 ;;^UTILITY(U,$J,358.3,34255,2)
 ;;=^5015560
 ;;^UTILITY(U,$J,358.3,34256,0)
 ;;=N07.0^^192^1994^8
 ;;^UTILITY(U,$J,358.3,34256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34256,1,3,0)
 ;;=3^Hereditary Nephropathy w/ Minor Glomerular Abnormality NEC
 ;;^UTILITY(U,$J,358.3,34256,1,4,0)
 ;;=4^N07.0
 ;;^UTILITY(U,$J,358.3,34256,2)
 ;;=^5015559
 ;;^UTILITY(U,$J,358.3,34257,0)
 ;;=N07.8^^192^1994^9
 ;;^UTILITY(U,$J,358.3,34257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34257,1,3,0)
 ;;=3^Hereditary Nephropathy w/ Morphologic Lesions NEC
 ;;^UTILITY(U,$J,358.3,34257,1,4,0)
 ;;=4^N07.8
 ;;^UTILITY(U,$J,358.3,34257,2)
 ;;=^5015567
 ;;^UTILITY(U,$J,358.3,34258,0)
 ;;=N41.9^^192^1994^10
 ;;^UTILITY(U,$J,358.3,34258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34258,1,3,0)
 ;;=3^Inflammatory Prostate Disease,Unspec
 ;;^UTILITY(U,$J,358.3,34258,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,34258,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,34259,0)
 ;;=N06.6^^192^1994^11
 ;;^UTILITY(U,$J,358.3,34259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34259,1,3,0)
 ;;=3^Isolated Proteinuria w/ Dense Deposit Disease
 ;;^UTILITY(U,$J,358.3,34259,1,4,0)
 ;;=4^N06.6
 ;;^UTILITY(U,$J,358.3,34259,2)
 ;;=^5015555
 ;;^UTILITY(U,$J,358.3,34260,0)
 ;;=N06.7^^192^1994^12
 ;;^UTILITY(U,$J,358.3,34260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34260,1,3,0)
 ;;=3^Isolated Proteinuria w/ Diffuse Crescentic Glomerulonephritis
